Sujoy Khan
Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia
Khan, Sujoy; Durairaj, Senthilkumar; Phumphukhieo, Punyarat; Holding, Stephen; Allsup, David
Authors
Senthilkumar Durairaj
Punyarat Phumphukhieo
Stephen Holding
Professor David Allsup D.J.Allsup@hull.ac.uk
Professor of Haematology
Citation
Khan, S., Durairaj, S., Phumphukhieo, P., Holding, S., & Allsup, D. (2021). Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia. Leukemia & Lymphoma, 1-8. https://doi.org/10.1080/10428194.2021.1885662
Journal Article Type | Letter |
---|---|
Acceptance Date | Jan 28, 2021 |
Online Publication Date | Feb 17, 2021 |
Publication Date | Feb 17, 2021 |
Deposit Date | Feb 18, 2021 |
Publicly Available Date | Feb 18, 2022 |
Journal | Leukemia and Lymphoma |
Print ISSN | 1042-8194 |
Electronic ISSN | 1029-2403 |
Publisher | Taylor and Francis |
Peer Reviewed | Peer Reviewed |
Pages | 1-8 |
DOI | https://doi.org/10.1080/10428194.2021.1885662 |
Keywords | Cancer Research; Oncology; Hematology |
Public URL | https://hull-repository.worktribe.com/output/3726327 |
Ensure healthy lives and promote well-being for all at all ages
Files
Article
(109 Kb)
PDF
Copyright Statement
©2021 The authors. All rights reserved. No part of this publication may be reproduced without the written permission of the copyright holder
You might also like
Epcoritamab in B-cell malignancies: current status and prospects
(2024)
Journal Article
Impact of Surface Ligand on the Biocompatibility of InP/ZnS Quantum Dots with Platelets
(2023)
Journal Article